Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dr Agarwal’s Health CareBOM:544350 +0.12%17 ROA % is 4.03% as of Mar. 2026, which is 11% above its 10-year median of 3.63. GuruFocus rates BOM:544350 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 854 Medical Devices & Instruments companies, Dr Agarwal’s Health Care ranks better than 63.23% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Dr Agarwal’s Health Care's annualizedNet Income for the quarter that ended in Mar. 2026 was ₹1,588 Mil.
Dr Agarwal’s Health Care's average Total Assets over the quarter that ended in Mar. 2026 was ₹39,418 Mil. Therefore, Dr Agarwal’s Health Care's annualized ROA % for the quarter that ended in Mar. 2026 was 4.03%.
The historical rank and industry rank for Dr Agarwal’s Health Care's ROA % or its related term are showing as below:
BOM:544350'
s ROA % Range Over the Past 10 Years
Min: 2.6 Med: 3.63 Max: 6.6
Current: 3.51
During the past 5 years, Dr Agarwal’s Health Care's highest ROA % was 6.60%. The lowest was 2.60%. And the median was 3.63%.
BOM:544350's ROA % is ranked better than 63.23% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 0.645
vs BOM:544350: 3.51
Dr Agarwal’s Health Care (BOM:544350) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Dr Agarwal’s Health Care's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Agarwal’s Health Care ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Dr Agarwal’s Health Care's ROA % distribution charts can be found below:
* The bar in red indicates where Dr Agarwal’s Health Care's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Dr Agarwal’s Health Care (BOM:544350) has a ROA % of 4.03% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dr Agarwal’s Health Care and its competitors. This is 11% above median its historical median of 3.63. Over the past decade, Dr Agarwal’s Health Care's ROA % has ranged from 2.60 to 6.60. According to the industry distribution chart, Dr Agarwal’s Health Care ranks #314 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 36.8%.
Is Dr Agarwal’s Health Care's ROA % too high?
Dr Agarwal’s Health Care's current ROA % of 4.03% is 11% above median its 10-year median of 3.63. Over the past 10 years, this metric has ranged from a low of 2.60 to a high of 6.60. The Medical Devices & Instruments industry median ROA % is 0.65. Dr Agarwal’s Health Care's value of 4.03% is 524.8% above this industry median. Based on the distribution chart, Dr Agarwal’s Health Care ranks #314 out of 854 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Dr Agarwal’s Health Care has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Dr Agarwal’s Health Care's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Dr Agarwal’s Health Care ranks #314 out of 854 companies for ROA %. This puts Dr Agarwal’s Health Care in the upper half of its industry. The industry median ROA % is 0.65. Dr Agarwal’s Health Care's value of 4.03% is 524.8% above this benchmark. Historically, Dr Agarwal’s Health Care's own ROA % has ranged from 2.60 to 6.60 over the past decade. While the company's 10-year median is 3.63 vs. the industry median of 0.65, Dr Agarwal’s Health Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.65, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Agarwal’s Health Care's current ROA % of 4.03% is 524.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Dr Agarwal’s Health Care and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Agarwal’s Health Care's current ROA % is 4.03%, which is 11% above median its own 10-year median of 3.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Agarwal’s Health Care stock overvalued right now?
Dr Agarwal’s Health Care (BOM:544350) has a current ROA % of 4.03%. The current ROA % is 4.03%, which is 11% above median its 10-year median of 3.63 and 524.8% above the Medical Devices & Instruments industry median of 0.65. Dr Agarwal’s Health Care's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Dr Agarwal’s Health Care (BOM:544350), the current ROA % is 4.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dr Agarwal's Health Care Ltd is engaged in eye care services, including cataract, refractive and other surgeries; consultations, diagnoses and non-surgical treatments; and sell opticals, contact lenses and accessories, and eye care related pharmaceutical products. It offer services such as Surgeries, Cataract surgeries, Refractive surgeries, Other surgeries, and Consultations, diagnoses and non-surgical treatments, Its products services include Sale of opticals and Sale of eye care-related pharmaceutical products. The company is engaged in single segment that is eye care and related services provided from its hospitals which are located in India and Africa. It generates maximum revenue from India.
17GF Score
Get the complete analysis for BOM:544350
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544350 has been successfully added to your 
